Cargando…
Cost-Effectiveness of Colchicine for Recurrent Cardiovascular Events
BACKGROUND: Colchicine is an anti-inflammatory therapy with a low associated cost that has been shown in 2 large studies to reduce cardiovascular (CV) events, but its use is associated with side effects. The main objective for this analysis is to determine whether colchicine therapy is cost-effectiv...
Autores principales: | Boczar, Kevin E., Beanlands, Rob, Wells, George, Coyle, Doug |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290950/ https://www.ncbi.nlm.nih.gov/pubmed/37377518 http://dx.doi.org/10.1016/j.cjco.2023.02.005 |
Ejemplares similares
-
Cost-Effectiveness of Canakinumab From a Canadian Perspective for Recurrent Cardiovascular Events
por: Boczar, Kevin E., et al.
Publicado: (2022) -
Examining anti-inflammatory therapies in the prevention of cardiovascular events: protocol for a systematic review and network meta-analysis of randomised controlled trials
por: Boczar, Kevin Emery, et al.
Publicado: (2022) -
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
por: Samuel, Michelle, et al.
Publicado: (2020) -
The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial
por: Boczar, Kevin Emery, et al.
Publicado: (2023) -
Observational Cross-Sectional Study of Inflammatory Markers After Transient Ischemic Attacks, Acute Coronary Syndromes, and Vascular Stroke Events
por: Boczar, Kevin E., et al.
Publicado: (2020)